Rigorous, reproducible, and robust experimental designs can ameliorate experimental constraints that have led to high rates of translational failure. Preclinical results can be affected by extrinsic and intrinsic factors that can be better modeled to improve translational success by embracing heterogeneity as an inherent biological phenomenon.